MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update

Go back to MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
(NASDAQ: INKT) Delayed: 11.33 +0.38 (3.47%)
Previous Close $10.95    52 Week High
Open $11.00    52 Week Low
Day High $11.42    P/E N/A 
Day Low $10.82    EPS
Volume 8,262